In the News

10/06/2020

8 quotes from Cleveland Clinic leaders on innovation, digital health and advice for IT leaders

At Cleveland Clinic, William Morris, MD, and Susan Bernat have been part of the team leading the development and commercialization arm of the academic medical center.

Dr. Morris is executive medical director of Cleveland Clinic Innovations, which is dedicated to turning medical inventions of employees into industry-advancing medical products and companies. Ms. Bernat serves as the general manager of strategic marketing.


10/06/2020

Cleveland Clinic Unveils Top 10 Medical Innovations For 2021

An up-and-coming gene therapy for blood disorders. A new class of medications for cystic fibrosis. Increased access to telemedicine. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of clinicians and researchers from Cleveland Clinic.


10/06/2020

Cleveland Clinic Unveils Top 10 Medical Innovations for 2021

An up-and-coming gene therapy for blood disorders. A new class of medications for cystic fibrosis. Increased access to telemedicine. These are some of the innovations that will enhance healing and change healthcare in the coming year, according to a distinguished panel of clinicians and researchers from Cleveland Clinic. 


10/06/2020

Is telemedicine over- or underhyped?

At the Cleveland Clinic 2020 Medical Innovation Summit, a panel of health system IT executives gathered to discuss the big issues in digital innovation today.

The discussion, moderated by CNBC reporter Chrissy Farr, included Boston-based Mass General Brigham Chief Digital Health Officer Alistair, Erskine, MD; Cleveland Clinic CIO Matt Kull; Winston-Salem, N.C.-based Novant Health Chief Digital and Technology Officer Angela Yochem; and Aurora, Colo.-based UCHealth Chief Innovation Officer Richard Zane, MD. While all panelists agreed that telehealth would be essential in the future, each organization was at a different stage of telehealth roll-out when the pandemic began and has different goals now.


10/05/2020

Coronavirus response, top innovations of 2020 highlight Tuesday’s Cleveland Clinic Medical Innovation Summit

The coronavirus pandemic and health care’s response to it, along with the unveiling of the annual Top 10 Medical Innovations list, are highlights of the Cleveland Clinic Medical Innovation Summit, which will be held Tuesday.


09/29/2020

Spotlight on Collaboration and Digital Innovation atClevelandClinicMedical Innovation Summit

The annual Cleveland Clinic Medical Innovation Summit, which will be held on October 6, features elements that are reflective of what's happening in the greater healthcare landscape: it's virtual; it's collaborative, featuring leaders of other healthcare systems for the first time ever; and there's a focus on the value of digital technology. Registration is free to convene a broad community from around the world to focus on how to continue the transformation of healthcare delivery that was spawned by a global pandemic.


07/28/2020

Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission

 Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today announced that its prophylactic breast cancer vaccine is making progress towards clinical trials. 


07/01/2020

Microbrush® Introduces New Nasopharyngeal Test Swabs

Microbrush, a leading US-based global manufacturer and supplier of flocked applicators, has launched a nasopharyngeal test swab to meet the growing demand for COVID-19 testing requirements.


06/30/2020

Third Frontier awards $2.4 million to Northeast Ohio universities and companies

The Ohio Third Frontier Commission has awarded $2.4 million to two Northeast Ohio universities and eight companies to help them advance new technologies into the marketplace. The funds were part of $5.34 million the state program awarded to universities and businesses across the state from its Technology Validation and Start-up Fund (TVSF).


02/20/2020

Long-term Changes in Gut Metabolite Predict CHD Risk

New longitudinal data underscore the role of the gut microbial metabolite trimethylamine N-oxide (TMAO) as a predictor of coronary heart disease (CHD) but also the potential for diet to modify its deleterious effects.


   <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >   

Get In Touch With Us